HappeningToo topic
Ofatumumab reports
Browse community reports connected to Ofatumumab. These reports can show that other people are describing similar experiences, but they do not prove that Ofatumumab caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
38 problems
Abdominal Discomfort while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and abdominal discomfort appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and alopecia appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and anxiety appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and back pain appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chills while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and chills appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and cough appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and decreased appetite appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and diarrhea appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and dizziness appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Excessive sweating while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and excessive sweating appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and fatigue appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and feeling abnormal appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Cold while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and feeling cold appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Hot while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and feeling hot appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and headache appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and hives appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Influenza Like Illness while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and influenza like illness appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and insomnia appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and itching appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and malaise appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Migraine while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and migraine appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and muscle spasms appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and muscular weakness appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and myalgia appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and nausea appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Oropharyngeal Pain while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and oropharyngeal pain appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and pain appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and rash appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and shortness of breath appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and sleepiness appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and tingling or pins and needles appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and tremor appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vertigo while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and vertigo appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vision Blurred while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and vision blurred appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and vomiting appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and weakness appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and weight decreased appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Ofatumumab
FDA FAERS contains adverse-event reports in which Ofatumumab and weight increased appear together. This does not establish that Ofatumumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →